REM Sleep Behavior Disorder clinical trials at UCLA
2 in progress, 1 open to eligible people
North American Prodromal Synucleinopathy Consortium Stage 2
open to eligible people ages 18 years and up
This study will enroll participants with idiopathic REM sleep behavior disorder (RBD) and healthy controls for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Los Angeles, California and other locations
North American Prodromal Synucleinopathy Consortium
Sorry, accepting new patients by invitation only
This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Los Angeles, California and other locations
Our lead scientists for REM Sleep Behavior Disorder research studies include Alon Avidan, MD, MPH.
Last updated: